<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00192959</url>
  </required_header>
  <id_info>
    <org_study_id>KF 02-065/03</org_study_id>
    <nct_id>NCT00192959</nct_id>
  </id_info>
  <brief_title>Xenon Inhalation During Orthopaedic Surgery in Elderly Subjects.</brief_title>
  <official_title>Xenon Inhalation as Cover Sedation During Orthopaedic Surgery in Elderly Subjects Comparing the Effects of Inhaled Xenon and Intravenous Propofol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Linde AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <brief_summary>
    <textblock>
      The primary objective was to explore the feasibility of inhaled xenon for sedation in terms&#xD;
      of its effect on postoperative cognitive function in elderly, in comparison with the&#xD;
      postoperative cognitive function found after IV propofol sedation in the same population.The&#xD;
      secondary objectives were designed to assess the feasibility of xenon sedation in terms of&#xD;
      its effects on different neuropsycho-logical test variables, vital signs, sedation levels and&#xD;
      safety in elderly orthopaedic subjects.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary endpoint: - The primary efficacy parameter was a combined score based on the seven&#xD;
      variables derived from four validated neuropsychological tests of cognitive function; Visual&#xD;
      Verbal Learning test, Concept Shifting test, Stroop Color Word Interference test and Letter&#xD;
      Digit Coding test. The parameter was used for comparing changes in test results between the&#xD;
      screening and first postoperative follow-up testing for the treatment groups.Secondary&#xD;
      endpoints:- Cognitive performance changes from baseline to the first post-operative follow-up&#xD;
      judged separately for each of the seven variables from the changes in the test results.-&#xD;
      Cognitive performance changes from baseline to the second postoperative follow-up judged&#xD;
      separately and globally for each of the seven variables from the changes in test results.-&#xD;
      Adequacy of ventilation (respiratory rate and pulse oximetry)- Adequacy of xenon sedation by&#xD;
      monitoring depth of unconsciousness, signs of airway irritation, need for additional&#xD;
      sedatives, time to recovery from anaesthesia. - Technical performance of xenon delivery&#xD;
      device&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2004</start_date>
  <completion_date>December 2004</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary endpoint: -cognitive function; Visual Verbal Learning test, Concept Shifting test, Stroop Color Word Interfer</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary endpoints:-</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital signs</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
  </secondary_outcome>
  <enrollment>44</enrollment>
  <condition>Anaesthesia</condition>
  <condition>Postoperative Cognitive Function</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xenon vs propofol</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female subjects â‰¥ 60 years of age.&#xD;
&#xD;
          -  American Soc. of Anaesthesiologists Physical Status Classification (ASA) I-III status&#xD;
             [27]&#xD;
&#xD;
          -  Referred for elective orthopaedic knee surgery with an anticipated duration of &gt; 45&#xD;
             min&#xD;
&#xD;
          -  Expected to remain in hospital for at least 3 days&#xD;
&#xD;
          -  Expected to be able to comply with the study protocol throughout the study period&#xD;
&#xD;
          -  Mini Mental State Examination (MMSE) score &gt; 23&#xD;
&#xD;
          -  Informed consent given&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Disease of the CNS (infectious, metabolic, tumours, dementia, epilepsy, major&#xD;
             psychiatric disease, confusion/ delirium according to Diagnostic &amp; Statistical Manual&#xD;
             of Mental Disorders (DSM) IV criteria)&#xD;
&#xD;
          -  Contradiction for spinal anaesthesia&#xD;
&#xD;
          -  Contradiction for laryngeal mask&#xD;
&#xD;
          -  Regular use of tranquillisers, or antidepressants, if prescribed by psychiatrist for&#xD;
             psychosis or depression&#xD;
&#xD;
          -  Undergone neuropsychological testing within the last year&#xD;
&#xD;
          -  Unable to follow study procedures, illiteracy, or poor comprehension of the language&#xD;
             used in the psychometric tests&#xD;
&#xD;
          -  Severe visual or auditory disorder&#xD;
&#xD;
          -  Alcoholism or drug abuse&#xD;
&#xD;
        CNS disease BMI &gt; 35 Inab&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars S Rasmussen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>June 2005</verification_date>
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 16, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>September 16, 2005</last_update_submitted>
  <last_update_submitted_qc>September 16, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2005</last_update_posted>
  <keyword>Anaesthesia</keyword>
  <keyword>Surgery</keyword>
  <keyword>Postoperative</keyword>
  <keyword>Neuropsychological test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

